NEW MJ NEWS

AbbVie to Host Third-Quarter 2022 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its third-quarter 2022 financial results on Friday, October 28, 2022, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-third-quarter-2022-earnings-conference-call-301639218.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Nabis (CSE: NAB) (OTC: NABIF) Changes Name to “Nabis Holdings Inc.” and Continuation Into BC

VANCOUVER, British Columbia, May 28, 2019 (GLOBE NEWSWIRE) — Nabis Holdings (CSE:…

Tetra Bio Pharma Inc. (TBPMF) Granted Two OTC Drug Identification Numbers (DIN) by Health Canada

Tetra Bio-Pharma Granted Two OTC Drug Identification Numbers (DIN) by Health Canada…

$INSY to Present at RBC Capital Markets 2016 Global Healthcare Conference

Insys Therapeutics, Inc. to Present at RBC Capital Markets 2016 Global Healthcare…